Hot Topics


Why is it a big mistake to link funding of R&D costs with drug prices?:

Letter to the 129th WHO Executive Board on conflicts of interest, WHO reform and the future of financing

24 May 2011

NGO letter on Conflicts of Interest, Future Financing, Reform and governance of the WHO.

Dear Members of the Executive Board,

SCP 16: Summary by the Chair

World Intellectual Property Organization

SCP/16/8 PROV.
DATE: MAY 20, 2011

Standing Committee on the Law of Patents

Sixteenth Session
Geneva, May 16 to 20, 2011


Agenda Item 1: Opening of the session

1. The sixteenth of the Standing Committee on the Law of Patents (SCP) was opened by Mr. James Pooley, Deputy Director General, who welcomed the participants. Mr. Philippe Baechtold (WIPO) acted as Secretary.

BRICS Health Ministers’ preparatory meeting – May 17th 2011

BRICS Health Ministers’ preparatory meeting – May 17th 2011
Press release

Consistent with the mandate of the Sanya Declaration of the BRICS Leaders Meeting (14 April 2011), the Ministers of Health of the five BRICS’ countries met on the sidelines of the 64thWorld Health Assembly, on 17 May 2011, to discuss issues of common interest as well as prepare the BRICS Health Ministerial Meeting to be held in Beijing, China, on 11 July 2011. Representatives of WHO and UNAIDS also attended the meeting.

SCP16: KEI intervention on Patents and Health

16th session of the WIPO Standing Committee of the Law of Patents (SCP)
Thursady, 19 May 2011

KEI Statement on Patents and Health

KEI is impressed by and fully supportive of the joint proposal of the African Group and the Development Agenda Group on a work program on Patents and Health, which has been published as SCP/16/7. We agree with the comments of the Chair that the proposal is both comprehensive and well thought out.

Brazil's statement to the 64th World Health Assembly on the future of financing

The future of financing for WHO A64/4
Provisional agenda item 11


At the outset we would like to thank the report by the Director-General on WHO reform and its future financing for a healthy future. We acknowledge the efforts to reflect comments and suggestions presented by Member-States throughout the ongoing consultation process and believe the document is a good basis for our continued debate on this important issue.

USPTO statement at WIPO side event on Medicines Patent Pool

This is the statement that was delivered by Karin L. Ferriter (from USPTO and USTR), at a UNITAID side event on the Medicines Patent Pool, during a break of the WIPO Standing Committee on the Law of Patents.

Statement on Medicines Patent Pool Side Event

NGO Statement on WHO governance and the Management of Conflicts of Interest and the Future of Financing for WHO

NGO Statement on WHO governance and the Management of Conflicts of Interest and the Future of Financing for WHO.

May 18, 2011

We write to express our concerns about governance of the World Health Organization (WHO) and other public health bodies, as regards the management of conflicts of interest.

SCP16: Slide presentations of Professor Carlos Correa, Judit Rius Sanjuan and James Love at KEI briefing on Patents and Health

On 17 May 2011, Knowledge Ecology International (KEI) organized a Briefing on Patents and Health at WIPO’s 16h session of the Standing Committee on Patents (SCP).

KEI comments to the WIPO patent committee discussion of patent quality

During today's discussion at the WIPO Standing Committee on the Law of Patents (SCP) on patent quality KEI make four points in its intervention.

1. WIPO should consider gathering information on the costs of litigation to challenge the validity of patents.

2. WIPO should consider creating a database to share information on the cases where litigation has resulted findings that patent claims as invalid.

WIPO patent committee discusses Exception and Limitations to Patent Rights

The World Intellectual Property Organization (WIPO) has convened the 16th session of the WIPO Standing Committee on the Law of Patents (SCP). The SCP elected Albert Tramposch, Administrator for Policy and External Affairs, USPTO as Chair.

Save the Date-17 May 2011-KEI @ WIPO Standing Committee on the Law of Patents: Patents and Health

Knowledge Ecology International: Patents and Health

DATE: Tuesday, 17 May 2011

TIME: 13:30-15h00

VENUE: Room B at the WIPO Main Building

Dramatic increase in waiting lists for AIDS Drug Assistance Programs, January 2010 to May 2011

ADAP waiting list AIDS Drug Assistance Programs (ADAP) are state run programs that provide medicines to low-income HIV-positive patients who either have limited or no insurance coverage. ADAPs are essential in providing life-saving medicines to low-income patients, but these programs are threatened by the high costs of treatment.

Dr. Balasubramaniam

On April 19, 2011, Dr Kumariah Balasubramaniam died at his home in Sri Lanka. Dr. Balasubramaniam, known to many as Dr. Bala, was described by Professor Colvin Gooneratne as "one of the most knowledgeable, resolute, articulate, versatile, resilient and in many other ways exceptionally brilliant health activists [the world] has produced." My tribute to Dr. Bala is in the Huffington Post. Prof.

Syndicate content